• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brawn Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4887.0
  • ISIN : INE899B01015
19.90 1 (4.13%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    19.90

  • Today’s High

    19.99

  • Open

    19.99

  • Perv Close

    19.11

  • 52W Low

    15.46

  • 52W High

    26.05

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    5.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.20

  • Debt-Equity Ratio

    4.13

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    5.97

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.00

  • BV (₹)

    11.20

  • Sales( ₹ in Cr.)

    13.47

  • NP (in Cr.)

    -1.80

  • NP Var(%)

    -45.0

  • Div%

    0.0

  • CPS (₹)

    -5.60

  • EPS (₹)

    -6.00

  • Traded Value (₹ in Lakhs)

    5.97

  • 52 Week High

    26.05

  • 52 Week Low

    15.46

  • Price BSE

    20.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    5.97

  • P/C Ratio

    -3.60

  • P/E Ratio

    -3.30

  • Price Vs.BV

    -6.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 16.49 22.23 8.62 34.98 49.62 65.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 16.49 22.23 8.62 34.98 49.62 65.18
Other Income 0.09 0.01 0.00 0.31 0.17 0.74
Stock Adjustments 1.23 0.07 4.47 -0.13 0.05 -0.01
Total Income 17.81 22.31 13.09 35.16 49.84 65.91
EXPENDITURE :            
Raw Materials 15.59 19.24 11.05 29.89 42.15 58.49
Power and Fuel Cost 0.08 0.06 0.02 0.04 0.05 0.05
Employee Cost 1.40 1.40 1.80 2.36 3.08 3.02
Other Manufacturing Expenses 0.35 0.34 0.40 1.64 1.56 0.13
Selling and Administration Expenses 1.76 1.55 1.81 1.50 2.07 2.29
Miscellaneous Expenses 0.01 0.00 0.01 0.01 0.02 0.01
Employee Benefit Expenses 1.40 1.40 1.80 2.36 3.08 3.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 19.20 22.60 15.09 35.44 48.93 64.00
Operating Profit -1.38 -0.29 -2.00 -0.29 0.90 1.91
Interest 0.06 0.01 0.06 0.04 0.05 0.07
Gross Profit -1.44 -0.30 -2.06 -0.33 0.85 1.84
Depreciation 0.10 0.11 0.05 0.03 0.03 0.03
Profit Before Tax -1.54 -0.41 -2.11 -0.36 0.82 1.81
Current Tax 0.00 -0.01 0.00 0.28 0.23 0.46
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.30 0.46 -0.47 -0.08 0.00 0.02
Reported Net Profit -1.25 -0.87 -1.64 -0.55 0.59 1.33
Extraordinary Items -0.01 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -1.24 -0.87 -1.64 -0.55 0.59 1.33
Adjustment below Net Profit 0.00 -0.04 0.07 0.08 0.01 -0.31
P & L Balance brought forward 1.19 2.10 3.68 4.14 3.54 2.51
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.05 1.19 2.10 3.68 4.14 3.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -4.16 -2.89 -5.48 -1.84 1.97 4.44
Earnings Per Share(Adj)-Unit Curr -4.16 -2.89 -5.48 -1.84 1.97 4.44
Book Value 16.88 21.03 24.07 29.31 30.87 28.85
Book Value(Adj)-Unit Curr 16.88 21.03 24.07 29.31 30.87 28.85

Shareholding Pattern

  • Promoter Group

    53.66%

  • Public Share Holding

    46.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 68,100 2.27 0 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,541,844 51.39 1,431,444 25
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,609,944 53.66 1,431,444 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 10,400 0.35 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,400 0.35 0 1
2] Non Institution
Bodies Corporate 11,318 0.38 11,218 16
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 39,041 1.30 19,041 32
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 95,672 3.19 95,672 3
Individuals holding nominal share capital up to Rs. 1 lakh 890,833 29.69 765,124 3,873
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 343,092 11.44 343,092 24
Sub Total 1,379,956 45.99 1,234,147 3,948
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,000,300 100.00 2,665,591 3,975

Company Background

Brawn Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brawn Biotech Ltd
  • BSE Code : 4887.0
  • ISIN : INE899B01015

  • Incorporation Year

    1985

  • Registered Office

    C-64 Lajpat Nagar-1 1st Floor
    , New Delhi,
    New Delhi-110024

  • Telephone

  • FAX

  • Chairman

    Brij Raj Gupta

  • Managing Director

  • Company Secretary

    Priyanka Sharma

  • Auditor

    Rajiv Udai & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    RCMC Share Registry Pvt Ltd
    B-25/1 First Floor ,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi-110020

Brawn Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brawn Biotech 19.90 16.58 16.49 -3.32 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10